Dedicated to serving significant unmet medical needs, GenFleet Therapeutics constructs its R&D platform on the basis of disease biology and translational medicine, and researches into latest biological mechanism of cancer pathways, tumor microenvironment and human immunoregulation. GenFleet's rich and diversified pipeline highlights multiple cutting-edge products with novel mechanisms and global intellectual property rights.
Through years of endeavor, GenFleet has set up industry-leading capabilities and expertise in developing novel drugs - both small molecules and biologics. Its cutting-edge pipeline includes over 10 products, three of which have progressed into clinical stages. As more projects move into late-stage clinical trials, GenFleet is expected to unravel its blueprint of commercialization during the next 3-5 years.
Company Details
- Employees
- 29
- Address
- Zhangjiang Road, Suite A,#1206,china
- Industry
- Pharmaceutical Manufacturing
- NAICS
-
Pharmaceutical and Medicine ManufacturingMedicinal and Botanical ManufacturingPharmaceutical Preparation ManufacturingIn-Vitro Diagnostic Substance ManufacturingBiological Product (except Diagnostic) Manufacturing
- Website
- http://www.genfleet.com/en
- HQ
- Shanghai
Genfleet Therapeutics Questions
Genfleet Therapeutics's website is http://www.genfleet.com/en
Genfleet Therapeutics's LinkedIn profile is https://cn.linkedin.com/company/genfleet-therapeutics
Genfleet Therapeutics has
29 employees.
View email and phone details for 29
employees at Genfleet Therapeutics.
Genfleet Therapeutics's industry is
Pharmaceutical Manufacturing
Genfleet Therapeutics's top competitors are
Cstone Pharmaceuticals,
Rgenta Therapeutics Inc.,
Vera Therapeutics, Inc.,
Innovent Biologics,
Institut Pasteur Of Shanghai,
Kura Oncology, Inc.,
和誉医药,
Verastem Oncology,
Summit Therapeutics, Inc.,
Highlight Capital.
Genfleet Therapeutics's categories are Pharmaceutical Manufacturing
